Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target

Secretory clusterin (sCLU) is associated with hepatocellular carcinoma (HCC) progression by contributing to angiogenesis, chemoresistance, cell survival, and metastasis. However, the sCLU expression at early stage of HCC progression remains to be clarified. In this study, the alteration of sCLU onco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Zheng, Wenjie, Yao, Min, Qian, Qi, Sai, Wenli, Qiu, Liwei, Yang, Junling, Wu, Wei, Dong, Zhizhen, Yao, Dengfu
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581031/
https://ncbi.nlm.nih.gov/pubmed/28881732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13674
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars